CASI Pharmeceuticals

Analyst Coverage

CASI Pharmaceuticals, Inc. is followed by the analyst(s) listed below. This list is provided for information purposes only. Please note that any opinions, estimates or forecasts regarding CASI Pharmaceutical’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of CASI Pharmaceuticals or its management. Analysts may be contacted directly for copies of their reports.

HC Wainwright & Co. Swayampakula Ramakanth (RK), Ph.D. sramakanth@hcwco.com
Zacks Small Cap Research Grant Zeng, CFA gzeng@zacks.com

About Us

A leading US-headquartered, NASDAQ-listed, biopharmaceutical company targeting the global market, with a focus on China.

Learn More

In the News

CASI's turnaround turns eastward; firm seeks to be Celgene of China

Read Article →

Poster

Clinical Safety and Efficacy of the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated, Locally Advanced or Metastatic Triple-Negative Breast Cancer

Download →

Poster

Rodman & Renshaw 19th Annual Global Investment Conference

Download →